From: A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
Age, median (years)
60.5 (range 37–81)
Gender
Male
24 (57.1)
Female
18 (42.9)
ECOG performance status
0
9 (21.4)
1
27 (64.3)
2
6 (14.3)
Primary tumour
Gallbladder
18
Bile ducts
22
Ampulla of vater
Metastatic disease at presentation
Yes
39
No
3